Sushrut Dharmakidari1, Pratik Bhattacharya1, Seemant Chaturvedi2. 1. St. Joseph Mercy Oakland Hospital, Pontiac, MI, USA. 2. Department of Neurology and Stroke Program, University of Miami Miller School of Medicine, 1120 NW 14th St., Room 1363, Miami, FL, 33136, USA. Schaturvedi@med.miami.edu.
Abstract
PURPOSE OF REVIEW: The purpose of the study was to update the recent information pertaining to carotid artery stenosis risk stratification and treatment. RECENT FINDINGS: Current decision-making related to carotid artery stenosis is based on clinical trials that are outdated. Medical therapy has improved considerably in the past two decades, and this has reduced the stroke rate for both symptomatic and asymptomatic carotid stenoses. In recent community-based studies, the stroke risk with asymptomatic stenosis has been < 1% per year. For asymptomatic carotid stenosis, new trials such as CREST 2 and ECST 2 will determine whether revascularization has any benefit beyond aggressive medical management. For symptomatic patients, carotid endarterectomy is associated with a lower periprocedural stroke rate compared to carotid stenting. Age greater than 70 years is also associated with an increased risk for carotid stenting patients. Clinicians should consider a variety of clinical and radiologic variables in reaching treatment decisions for patients with carotid stenosis. Both symptomatic and asymptomatic patients should receive optimal medical therapy.
PURPOSE OF REVIEW: The purpose of the study was to update the recent information pertaining to carotid artery stenosis risk stratification and treatment. RECENT FINDINGS: Current decision-making related to carotid artery stenosis is based on clinical trials that are outdated. Medical therapy has improved considerably in the past two decades, and this has reduced the stroke rate for both symptomatic and asymptomatic carotid stenoses. In recent community-based studies, the stroke risk with asymptomatic stenosis has been < 1% per year. For asymptomatic carotid stenosis, new trials such as CREST 2 and ECST 2 will determine whether revascularization has any benefit beyond aggressive medical management. For symptomatic patients, carotid endarterectomy is associated with a lower periprocedural stroke rate compared to carotid stenting. Age greater than 70 years is also associated with an increased risk for carotid stenting patients. Clinicians should consider a variety of clinical and radiologic variables in reaching treatment decisions for patients with carotid stenosis. Both symptomatic and asymptomatic patients should receive optimal medical therapy.
Authors: Jan Luedemann; Ulf Schminke; Klaus Berger; Marion Piek; Stefan N Willich; Angela Döring; Ulrich John; Christof Kessler Journal: Stroke Date: 2002-12 Impact factor: 7.914
Authors: Pierre Amarenco; Julien Bogousslavsky; Alfred Callahan; Larry B Goldstein; Michael Hennerici; Amy E Rudolph; Henrik Sillesen; Lisa Simunovic; Michael Szarek; K M A Welch; Justin A Zivin Journal: N Engl J Med Date: 2006-08-10 Impact factor: 91.245
Authors: S Chaturvedi; A Bruno; T Feasby; R Holloway; O Benavente; S N Cohen; R Cote; D Hess; J Saver; J D Spence; B Stern; J Wilterdink Journal: Neurology Date: 2005-09-27 Impact factor: 9.910
Authors: Larry B Goldstein; Cheryl D Bushnell; Robert J Adams; Lawrence J Appel; Lynne T Braun; Seemant Chaturvedi; Mark A Creager; Antonio Culebras; Robert H Eckel; Robert G Hart; Judith A Hinchey; Virginia J Howard; Edward C Jauch; Steven R Levine; James F Meschia; Wesley S Moore; J V Ian Nixon; Thomas A Pearson Journal: Stroke Date: 2010-12-02 Impact factor: 7.914
Authors: J David Spence; Victoria Coates; Hector Li; Arturo Tamayo; Claudio Muñoz; Daniel G Hackam; Maria DiCicco; Janine DesRoches; Chrysi Bogiatzi; Jonathan Klein; Joaquim Madrenas; Robert A Hegele Journal: Arch Neurol Date: 2009-12-14
Authors: J S Fine-Edelstein; P A Wolf; D H O'Leary; H Poehlman; A J Belanger; C S Kase; R B D'Agostino Journal: Neurology Date: 1994-06 Impact factor: 9.910
Authors: Barbara Rantner; Barbara Kollerits; Gary S Roubin; Peter A Ringleb; Olaf Jansen; George Howard; Jeroen Hendrikse; Alison Halliday; John Gregson; Hans-Henning Eckstein; David Calvet; Richard Bulbulia; Leo H Bonati; Jean-Pierre Becquemin; Ale Algra; Martin M Brown; Jean-Louis Mas; Thomas G Brott; Gustav Fraedrich Journal: Stroke Date: 2017-04-28 Impact factor: 7.914
Authors: Akram A Hosseini; Richard J Simpson; Nishath Altaf; Philip M Bath; Shane T MacSweeney; Dorothee P Auer Journal: Stroke Date: 2017-02-14 Impact factor: 7.914